Print ISSN: 2395-1443
Online ISSN: 2395-1451
CODEN : IJCEKF
Indian Journal of Clinical and Experimental Ophthalmology (IJCEO) is open access, a peer-reviewed medical journal, published quarterly, online, and in print, by the Innovative Education and Scientific Research Foundation (IESRF) since 2015. To fulfil our aim of rapid dissemination of knowledge, we publish articles ‘Ahead of Print’ on acceptance. In addition, the journal allows free access (Open Access) to its content, which is likely to attract more readers and citations of articles published in IJCEO. Manuscripts must be prepared in more...Original Article
Author Details :
Volume : 5, Issue : 4, Year : 2019
Article Page : 417-421
https://doi.org/10.18231/j.ijceo.2019.101
Abstract
Aim: To study retinal changes among patients presenting with pregnancy induced hypertension
Material and Methods: Patients who fulfilled diagnostic criteria of pregnancy induced hypertension were
enrolled.
Results: Total 100 patients were examined among which 21 patients had grade I hypertensive changes, 32
showed grade II changes, 8 and 3 patients had grade III and IV retinopathy respectively. Three patients
developed serous retinal detachment.
Conclusion: We conclude that sixty four percent of patients with pregnancy induced hypertension had
related retinopathy. Focal spasms or generalized arteriolar attenuation were the most common vascular
findings. Grade III and Grade IV retinopathy changes were more frequently noted in patients with severe
preeclampsia and eclampsia.
Keywords: Retinal changes, Pregnancy induced hypertension.
How to cite : Akansha, Arpita, Kumar R, Study of retinal changes among patients presenting with pregnancy induced hypertension. Indian J Clin Exp Ophthalmol 2019;5(4):417-421
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.